Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects. Blood 2008 Jan 15;111(2):954-62

Date

10/12/2007

Pubmed ID

17928532

Pubmed Central ID

PMC2200850

DOI

10.1182/blood-2007-05-089573

Scopus ID

2-s2.0-38349188886 (requires institutional sign-in at Scopus site)   44 Citations

Abstract

Graft-versus-host disease (GVHD) remains a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation. Migration of donor-derived T cells into GVHD target organs plays an essential role in the development of GVHD. beta2 integrins are critically important for leukocyte extravasation through vascular endothelia and for T-cell activation. We asked whether CD18-deficient T cells would induce less GVHD while sparing the graft-versus-leukemia (GVL) effect. In murine allogeneic bone marrow transplantation models, we found that recipients of CD18-/- donor T cells had significantly less GVHD morbidity and mortality compared with recipients of wild-type (WT) donor T cells. Analysis of alloreactivity showed that CD18-/- and WT T cells had comparable activation, expansion, and cytokine production in vivo. Reduced GVHD was associated with a significant decrease in donor T-cell infiltration of recipient intestine and with an overall decrease in pathologic scores in intestine and liver. Finally, we found that the in vivo GVL effect of CD18-/- donor T cells was largely preserved, because mortality of the recipients who received transplants of CD18-/- T cells plus tumor cells was greatly delayed or prevented. Our data suggest that strategies to target beta2 integrin have clinical potential to alleviate or prevent GVHD while sparing GVL activity.

Author List

Liang Y, Liu C, Djeu JY, Zhong B, Peters T, Scharffetter-Kochanek K, Anasetti C, Yu XZ

Author

Xue-Zhong Yu MD Professor in the Microbiology and Immunology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Animals
Bone Marrow Transplantation
CD18 Antigens
Cell Movement
Cytokines
Disease Models, Animal
Graft vs Host Disease
Graft vs Leukemia Effect
Humans
Intestines
Liver
Lymphocyte Activation
Mice
Mice, Inbred BALB C
Mice, Mutant Strains
T-Lymphocytes
Transplantation, Homologous